Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

December 09, 2019

Evaluation of Container Systems with Residual Seal Force (RSF)

Parenteral drug products must be stored in a container system that provides good container closure integrity (CCI) over shelf life for the purpose of preventing environmental contamination. This system typically comprises a glass vial, elastomer stopper, and an aluminum seal. USP Chapter &lt;1207&gt; <em>Packaging Integrity Evaluation &ndash; Sterile Products</em> discusses in detail methods to measure CCI to determine if the system can meet the maximum allowable leak limit (MALL) for its specific drug product (i.e., the smallest gap, or leak rate, that places quality at risk). Critical to achieving good CCI is proper capping of the vial with the stopper and seal, making sure that the compression level of the stopper is appropriate.
West Pharma

Mary Tan

Specialist, Scientific Affairs, Singapore, Jurong

Previous Posts

December 06, 2019

Advantages of Fluoropolymer-Laminated Components

Candice Sun

Candice Sun

Specialist, Scientific Affairs, CN

Introducing Integrated Solutions

November 22, 2019

Combination Products: The Top Three Regulatory Challenges

Shari Krusniak

Shari Krusniak

Director, Marketing, Contract Manufacturing & Integrated Solutions

West Ready Pack

November 15, 2019

Processing and Selecting the Right Seal

Xiaoyu Xiang

Dr. Xiaoyu Xiang

Specialist, TCS, Commercial

By Your Side for Innovation

November 13, 2019

By Your Side for Speed to Market

Chris Ryan

Chris Ryan

VP & GM, Global Generics

Load more